SCHEMBL24718552

SCHEMBL24718552

Nc1ccc2nnc(N)n2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
ADORA2A P29274 1/20 0.56
ADORA2B P29275 1/20 0.56
ADORA1 P30542 1/20 0.56
CREBBP Q92793 1/20 0.56
MET P08581 2/20 0.39
KDM4E B2RXH2 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 2/20 0.38
RET P07949 2/20 0.36
FGFR1 P11362 2/20 0.36
FLT1 P17948 2/20 0.36
KDR P35968 2/20 0.36
FLT3 P36888 2/20 0.36
ALK Q9UM73 2/20 0.36
PIM1 P11309 1/20 0.36
PIM3 Q86V86 1/20 0.36
MALT1 Q9UDY8 1/20 0.36
CHEK1 O14757 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2763564 0.78 KDM4E (0.64) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL4296651 0.78 KDM4E (0.60) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL13746159 0.78 BRD4 (0.37) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL24718931 0.78 BRD4 (0.53) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL14927151 0.78 BRD4 (0.58) BRD4ADORA3ADORA2AADORA2BADORA1
Bromide SCHEMBL1188167 0.77 KDM4E (0.62) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL2362190 0.74 ALDH1A1 (0.64) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL1188236 0.74 PDE10A (0.35) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL12878973 0.74 KDM4E (0.38) BRD4ADORA3ADORA2AADORA2BADORA1
SCHEMBL10806414 0.72 KDM4E (0.65) BRD4ADORA3ADORA2AADORA2BADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022253188-A1 NITROGEN-CONTAINING FUSED HETEROAROMATIC BICYCLIC COMPOUNDS AS USP1 INHIBITORS AND THE USE THEREOF IMPACT THERAPEUTICS (SHANGHAI) , INC (CN) 2022-12-08 WO disclosed